Literature DB >> 17630042

The challenge of managing drug interactions in elderly people.

Louise Mallet1, Anne Spinewine2, Allen Huang3.   

Abstract

Drug therapy is essential when caring for elderly patients, but clearly it is a double-edged sword. Elderly patients are at high risk of having drug interactions, but the prevalence of these interactions is not well documented. Several types of interactions exist: drug-drug, drug-disease, drug-food, drug-alcohol, drug-herbal products, and drug-nutritional status. Factors such as age-related changes in pharmacokinetics and pharmacodynamics, frailty, interindividual variability, reduced homoeostatic mechanisms, and psychosocial issues need to be considered when drug interactions are assessed. Software can help clinicians to detect drug interactions, but many programmes have not been updated with the evolving knowledge of these interactions, and do not take into consideration important factors needed to optimise drug treatment in elderly patients. Any generated recommendations have to be tempered by a holistic, geriatric, multiprofessional approach that is team-based. This second paper in a series of two on prescribing in elderly people proposes an approach to categorise drug interactions, along with strategies to assist in their detection, management, and prevention.

Entities:  

Mesh:

Year:  2007        PMID: 17630042     DOI: 10.1016/S0140-6736(07)61092-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  141 in total

1.  Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study.

Authors:  Paulo Roque Obreli-Neto; Alessandro Nobili; André de Oliveira Baldoni; Camilo Molino Guidoni; Divaldo Pereira de Lyra Júnior; Diogo Pilger; Juliano Duzanski; Mauro Tettamanti; Joice Mara Cruciol-Souza; Walderez Penteado Gaeti; Roberto Kenji Nakamura Cuman
Journal:  Eur J Clin Pharmacol       Date:  2012-05-30       Impact factor: 2.953

2.  The Paradox of Scarcity in a Land of Plenty: Meeting the Needs of Older Adults with Mental Health and Substance Use Disorders.

Authors:  Stephen J Bartels; Renee Pepin; Lydia E Gill
Journal:  Generations       Date:  2014

Review 3.  Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment.

Authors:  Andrew J McLachlan; Sally Bath; Vasi Naganathan; Sarah N Hilmer; David G Le Couteur; Stephen J Gibson; Fiona M Blyth
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

4.  Evaluation of drug-drug interaction screening software combined with pharmacist intervention.

Authors:  Cristiano S Moura; Nília M Prado; Najara O Belo; Francisco A Acurcio
Journal:  Int J Clin Pharm       Date:  2012-04-26

Review 5.  Prescribing for older people.

Authors:  James C Milton; Ian Hill-Smith; Stephen H D Jackson
Journal:  BMJ       Date:  2008-03-15

Review 6.  Do we learn the right things from clinical trials?

Authors:  Silvio Garattini; Vittorio Bertele'
Journal:  Eur J Clin Pharmacol       Date:  2008-01-29       Impact factor: 2.953

Review 7.  The clinical implications of ageing for rational drug therapy.

Authors:  Shaojun Shi; Klaus Mörike; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-01-05       Impact factor: 2.953

8.  Effect of multiple pharmacy use on medication adherence and drug-drug interactions in older adults with Medicare Part D.

Authors:  Zachary A Marcum; Julia Driessen; Carolyn T Thorpe; Walid F Gellad; Julie M Donohue
Journal:  J Am Geriatr Soc       Date:  2014-01-21       Impact factor: 5.562

9.  Use and perceived benefits of mobile devices by physicians in preventing adverse drug events in the nursing home.

Authors:  Steven M Handler; Richard D Boyce; Frank M Ligons; Subashan Perera; David A Nace; Harry Hochheiser
Journal:  J Am Med Dir Assoc       Date:  2013-10-02       Impact factor: 4.669

10.  Motoric Cognitive Risk Syndrome in Polypharmacy.

Authors:  Claudene J George; Joe Verghese
Journal:  J Am Geriatr Soc       Date:  2020-02-24       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.